Gentlemen/gentlewomen - your current cashflow arguments may be moot at this point. If you review several recent posts from Biobillionair that highlight his recent FDA info sleuthing, the Anchor label may be going on Vascepa in the immediate future! That means almost right now, so that may blow current sales estimates off the charts!
Sir, I understand what a cash flow statement is, as I own two substantial companies. You are the one referencing a cash flow statement, not me. Anyway, enough said.